Stocks · News reference
Veritone shares are trading lower after the company reported mixed Q2 financial results and cut its FY26 sales guidance below estimates.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 8:27 PM
- Checked
- Aug 13, 2026, 8:27 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
Top analysts changed outlook on top names. Mizuho raised price target for AIT from $355 to $400. See how analysts view AIT, ETON, PLGO, BRZE, VERI, POWL, AMAT, and YETI.
Read original at benzingaNeedham Maintains Buy on Veritone, Lowers Price Target to $5
Needham analyst Joshua Reilly maintains Veritone (NASDAQ:VERI) with a Buy and lowers the price target from $10 to $5.
Read original at benzingaWhy Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
Read original at benzinga